In cultured RCC cells, the inhibition of FLOT1 by miR-182-5p reduces the phosphorylation and activation of AKT2 and subsequent phosphorylation of FOXO3a (Xu et al., 2014). Here, AKT2 is linked to renal cell carcinoma.